The Thoracic Surgery team at Ruijin Hospital, led by Prof. Hecheng Li, has successfully performed Shanghai’s first segmentectomy using the SHURUI® single-port robotic system—marking a new milestone in precision thoracic surgery.
The 67-year-old patient presented with a growing solid nodule in the left lower lobe. PET-CT imaging indicated a high risk of malignancy (SUVmax 8.6). After multidisciplinary consultation and 3D reconstruction, the team opted for a targeted subsegmental resection (L-S6a) using the SHURUI® platform to preserve as much healthy lung tissue as possible.
On June 3, the surgery was completed through a single 3.5 cm intercostal incision in just 30 minutes, with minimal bleeding (20 ml). The patient recovered well and was discharged on postoperative day three.
This achievement underscores Ruijin’s expanding leadership in minimally invasive robotic surgery. The team is now advancing SHURUI® surgical system’s integration across campuses to deliver ultra-precise, low-impact care to a broader patient population.
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.